concept

GENETIC MODIFIERS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GENETIC MODIFIERS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

141Connections

0Hypotheses

1Analyses

50Outgoing

50Incoming

Summary

GENETIC MODIFIERS is a concept in neurodegeneration research. Key relationships include: associated with, regulates, protects against. Associated with Aging, Als, Alzheimer. Connected to 60 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	GENETIC MODIFIERS
Related Diseases	Autosomal-Dominant Alzheimer's Disease, Disease Onset, Alzheimer, Huntington, Ms

Wiki Pages (20)

Knowledge base pages for this entity

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Pathway Diagram

graph TD
    GENETIC_MODIFIERS["<b>GENETIC MODIFIERS</b>"]
    GENETIC_MODIFIERS -->|"modulates"| Autosomal_Dominant_Alzheimer_s["Autosomal-Dominant Alzheimer's Disease"]
    GENETIC_MODIFIERS -.protects against.-> Alzheimer["Alzheimer"]
    GENETIC_MODIFIERS -->|"target for"| Ms["Ms"]
    GENETIC_MODIFIERS -->|"target for"| Als["Als"]
    GENETIC_MODIFIERS -->|"regulates"| Tumor["Tumor"]
    GENETIC_MODIFIERS -->|"regulates"| Cancer["Cancer"]
    GENETIC_MODIFIERS -.protects against.-> Phagocytosis["Phagocytosis"]
    GENETIC_MODIFIERS -->|"target for"| AND["AND"]
    GENETIC_MODIFIERS -->|"inhibits"| MYELIN["MYELIN"]
    PHAGOCYTOSIS["PHAGOCYTOSIS"] -.protects against.-> GENETIC_MODIFIERS
    REELIN["REELIN"] -.protects against.-> GENETIC_MODIFIERS
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -.protects against.-> GENETIC_MODIFIERS
    MICROGLIA["MICROGLIA"] -.protects against.-> GENETIC_MODIFIERS
    ALZHEIMER["ALZHEIMER"] -.protects against.-> GENETIC_MODIFIERS
    NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -.protects against.-> GENETIC_MODIFIERS
    JUN["JUN"] -.protects against.-> GENETIC_MODIFIERS
    AND -->|"expressed in"| GENETIC_MODIFIERS
    GENES["GENES"] -->|"regulates"| GENETIC_MODIFIERS
    PLIN2["PLIN2"] -->|"expressed in"| GENETIC_MODIFIERS
    DNA["DNA"] -->|"regulates"| GENETIC_MODIFIERS
    MUTYH["MUTYH"] -->|"regulates"| GENETIC_MODIFIERS

Outgoing (90)

Target	Relation	Type	Str
Autosomal-Dominant Alzheimer's Disease	modulates	disease	0.85
Disease Onset	modulates	phenotype	0.85
Alzheimer	protects_against	disease	0.65
Huntington	associated_with	disease	0.65
Ms	therapeutic_target	disease	0.65
Als	therapeutic_target	disease	0.65
Ms	inhibits	disease	0.65
Ms	regulates	disease	0.65
Als	associated_with	disease	0.65
Obesity	associated_with	disease	0.65
Schizophrenia	associated_with	disease	0.65
Ms	associated_with	disease	0.65
Hypertension	associated_with	disease	0.65
Autism	associated_with	disease	0.65
Alzheimer	associated_with	disease	0.65
Carcinoma	associated_with	disease	0.65
Cancer	associated_with	disease	0.65
Aging	associated_with	disease	0.65
Tumor	associated_with	disease	0.65
Tumor	regulates	disease	0.65
Cancer	regulates	disease	0.65
Dementia	biomarker_for	disease	0.65
Als	biomarker_for	disease	0.65
Aging	biomarker_for	disease	0.65
Schizophrenia	biomarker_for	disease	0.65
Amyotrophic Lateral Sclerosis	biomarker_for	disease	0.65
Ftd	associated_with	disease	0.65
Ms	biomarker_for	disease	0.65
Frontotemporal Dementia	biomarker_for	disease	0.65
Als	activates	disease	0.65
Alzheimer	activates	disease	0.65
Tauopathy	activates	disease	0.65
ALS	causes	disease	0.65
ALS	activates	disease	0.65
Dementia	expressed_in	disease	0.65
Amyotrophic Lateral Sclerosis	expressed_in	disease	0.65
ALS	expressed_in	disease	0.65
Frontotemporal Dementia	expressed_in	disease	0.65
Phagocytosis	protects_against	pathway	0.60
FAN1	associated_with	gene	0.60
HTT	associated_with	gene	0.60
HUNTINGTON	associated_with	gene	0.60
DNA	associated_with	gene	0.60
PMS2	associated_with	gene	0.60
PHAGOCYTOSIS	associated_with	gene	0.60
MICROGLIA	associated_with	gene	0.60
MYELIN	inhibits	gene	0.60
AMYLOID	inhibits	gene	0.60
Phagocytosis	associated_with	pathway	0.60
Mitochondrial Function	regulates	pathway	0.60

Incoming (51)

Source	Relation	Type	Str
PHAGOCYTOSIS	protects_against	gene	0.60
REELIN	protects_against	gene	0.60
ALZHEIMER'S DISEASE	protects_against	gene	0.60
MICROGLIA	protects_against	gene	0.60
ALZHEIMER	protects_against	gene	0.60
GENES	associated_with	gene	0.60
RELN	associated_with	gene	0.60
NEURODEGENERATIVE DISEASES	protects_against	gene	0.60
JUN	protects_against	gene	0.60
APOE	associated_with	gene	0.60
MSH3	associated_with	gene	0.60
GENES	regulates	gene	0.60
PLIN2	expressed_in	gene	0.60
DNA	regulates	gene	0.60
MUTYH	regulates	gene	0.60
AND	expressed_in	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	biomarker_for	gene	0.60
TMEM106B	associated_with	gene	0.60
NEURODEGENERATIVE DISORDERS	biomarker_for	gene	0.60
PROGRANULIN	biomarker_for	gene	0.60
DEMENTIA	biomarker_for	gene	0.60
GRN	associated_with	gene	0.60
AND	associated_with	gene	0.60
C9ORF72	associated_with	gene	0.60
TAU	activates	gene	0.60
ALZHEIMER	activates	gene	0.60
GENES	activates	gene	0.60
MAPT	activates	gene	0.60
ALZHEIMER'S DISEASE	activates	gene	0.60
DNA	associated_with	gene	0.60
HTT	causes	gene	0.60
HUNTINGTIN	associated_with	gene	0.60
HUNTINGTON	associated_with	gene	0.60
PSP	activates	gene	0.60
AND	activates	gene	0.60
NEURODEGENERATIVE DISEASES	activates	gene	0.60
VPS29	activates	gene	0.60
DEMENTIA	expressed_in	gene	0.60
REPEAT-CONTAINING TRANSCRIPTS	expressed_in	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	expressed_in	gene	0.60
RNA	interacts_with	gene	0.60
RAN	expressed_in	gene	0.60
AND	interacts_with	gene	0.60
C9ORF72	expressed_in	gene	0.60
CANCER	regulates	gene	0.60
disease	associated_with	disease	0.50
HUNTINGTIN	interacts_with	protein	0.50
HUNTINGTON	interacts_with	gene	0.50
disease	interacts_with	disease	0.50
Dna Repair	interacts_with	pathway	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Do different priming stimuli require distinct therapeutic approaches or share co

immunology | 2026-04-08 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

GENETIC MODIFIERS

Understanding Entity Pages

Summary

Wiki Pages (20)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Corticobasal Syndrome (CBS)

Parkinson's Disease

Corticobasal Degeneration (CBD)

p-tau-217

ftd-tdp-pathology

Huntington's Disease

GBA Pathway in Parkinson's Disease

prion-disease

Pre-symptomatic Conversion Windows in ALS Genetic Risk Carriers

Alpha-Synuclein Prion-Like Spreading Mechanisms in Parkinson's Disease

CREB Signaling in Neurodegeneration

Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)

Excitotoxicity in Neurodegeneration

Gemin-8 Protein

PEN2 Gene

Beta-Secretase (BACE1) Protein

Fatal Familial Insomnia

Experiment Prioritization Index — Neurodegeneration